Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 310.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 129.0 | 53 | |
RA2159 | PI103 | 0.1 | uM | 1 | M-CSF | 156.0 | 62 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 437.0 | 52 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 373.0 | 51 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 495.0 | 59 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 513.5 | 68 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 524.5 | 78 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | M-CSF | 236.0 | 50 | |
N2586 | PI103 | 0.1 | uM | 1 | M-CSF | 159.0 | 44 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | M-CSF | 140.0 | 55 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 142.0 | 60 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 112.0 | 55 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 137.5 | 68 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 134.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 136.0 | 68 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | M-CSF | 137.0 | 94 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | M-CSF | 202.5 | 70 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 204.0 | 72 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 158.0 | 61 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 162.5 | 44 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 179.5 | 58 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | M-CSF | 159.5 | 54 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | M-CSF | 169.0 | 63 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | M-CSF | 131.0 | 84 |